Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28577615 | 0.80 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| SCHEMBL6585722 | 0.78 | GAA (0.56) | GAACA1CA2CA12CA9 | |
| SCHEMBL118977 | 0.76 | GAA (0.54) | GAACA1CA2CA12CA9 | |
| SCHEMBL1721592 | 0.76 | GAA (0.54) | GAACA1CA2CA12CA9 | |
| SCHEMBL13783355 | 0.74 | GAA (0.52) | GAACA1CA2CA12CA9 | |
| SCHEMBL27524270 | 0.73 | CA1 (0.52) | GAACA1CA2CA12CA9 | |
| SCHEMBL6547519 | 0.73 | GAA (0.50) | GAACA1CA2CA12CA9 | |
| SCHEMBL2493552 | 0.73 | GAA (0.50) | GAACA1CA2CA12CA9 | |
| SCHEMBL2499107 | 0.71 | GAA (0.48) | GAACA1CA2CA12CA9 | |
| SCHEMBL170033 | 0.71 | GAA (1.00) | GAACA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101528755-B | Gold complex, method for producing same, and organic ultraviolet electroluminescent element using same | UBE INDUSTRIES | 2012-07-04 | — | — | CN | disclosed |
| EP-2415746-A1 | LIGHT-EMITTING ELEMENT MATERIAL PRECURSOR BODY AND PRODUCTION METHOD THEREFOR | Toray Industries, Inc. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120012833-A1 | LIGHT-EMITTING ELEMENT MATERIAL PRECURSOR AND PRODUCTION METHOD THEREFOR | TORAY INDUSTRIES, INC. (JP) | 2012-01-19 | — | — | US | disclosed |
| CN-101528755-A | Gold complex, method for producing same, and organic ultraviolet electroluminescent element using same | UBE INDUSTRIES (JP) | 2009-09-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120012833-A1 | LIGHT-EMITTING ELEMENT MATERIAL PRECURSOR AND PRODUCTION METHOD THEREFOR | AHR, ARNT, CRY1 | GAA 3836/4885CA1 4067/4885CA2 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.